Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program
Malcolm A. Smith, Christopher L. Morton, Doris A. Phelps, E. Anders Kolb, Richard Lock, Hernan Carol, C. Patrick Reynolds, John M. Maris, Stephen T. Keir, Jianrong Wu, Peter J. Houghton
Producción científica: Article › revisión exhaustiva
27Citas
(Scopus)
Huella
Profundice en los temas de investigación de 'Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program'. En conjunto forman una huella única.